Search - tctmd.com

Displaying 681 - 700 of 3384

Sort: Relevancy | Date

Presentation NY Valves 2024

3 Reasons Why… TAVR First Is the Best Option!

Presenter: Mayra Guerrero

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Always Consider Root Enlargement for Lifetime Management

Presenter: Bo Yang

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Presenter: Nirat Beohar

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Would Never Use a Mechanical Valve

Presenter: Anelechi Anyanwu

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Would Recommend a Mechanical Valve

Presenter: Michael J. Mack

June 05, 2024

Presentation NY Valves 2024

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Presenter: Melissa Yen Yen Moey

June 05, 2024

Presentation NY Valves 2024

Case Presentation: A Healthy 55 Year-Old With Severe AS

Presenter: Michael I. Brener

June 05, 2024

Podcast TCTMD Talking Points

The TRISCEND II Trial

May 22, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

News Conference News

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

Yael L. Maxwell

May 09, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

Advertisement

3 Reasons Why… TAVR First Is the Best Option!

3 Reasons Why… I Always Consider Root Enlargement for Lifetime Management

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

3 Reasons Why… I Would Never Use a Mechanical Valve

3 Reasons Why… I Would Recommend a Mechanical Valve

Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement

Case Presentation: A Healthy 55 Year-Old With Severe AS

The TRISCEND II Trial

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

FDA Approves TriClip TEER Device for Tricuspid Repair

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content